Actinium Pharmaceuticals ATNM Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Continue MLEC Q2 2025 Earnings Narrower Loss than Expected as Stock Rises HWC Q1 2026 Earnings Modest EPS Beat Amid Stable Operating Environment ASRV Q1 2026 Earnings Positive EPS Reported Amid Quiet Quarter HBIO Q1 2026 Earnings Loss Narrower Than Expected on Cost Controls KEP Q4 2025 Earnings EPS Miss Amid Operational Challenges